AG
AGIO icon

Algert Global’s Agios Pharmaceuticals AGIO Stock Holding History

Algert Global’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.2M Sell
248,007
-20,428
-8% -$620K 0.11% 299
2026
Q1 		$9.08M Sell
268,435
-145,783
-35% -$4.13M 0.14% 233
2025
Q4 		$11.3M Buy
414,218
+378,448
+1,058% +$13.3M 0.18% 160
2025
Q3 		$1.44M Sell
35,770
-53,060
-60% -$2M 0.02% 768
2025
Q2 		$2.95M Buy
88,830
+14,020
+19% +$425K 0.06% 506
2025
Q1 		$2.19M Buy
74,810
+62,570
+511% +$2.08M 0.05% 576
2024
Q4 		$402K Sell
12,240
-25,116
-67% -$1.18M 0.01% 952
2024
Q3 		$1.66M Sell
37,356
-2,900
-7% -$132K 0.04% 619
2024
Q2 		$1.74M Sell
40,256
-2,110
-5% -$76.2K 0.06% 513
2024
Q1 		$1.24M Buy
+42,366
New +$1.13M 0.05% 557
2023
Q1 		– Sell
-13,852
Closed -$389K – 1123
2022
Q4 		$389K Sell
13,852
-37,200
-73% -$1.05M 0.02% 875
2022
Q3 		$1.44M Buy
+51,052
New +$1.37M 0.09% 398

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Algert Global's AGIO Position: Q2 2026 in Review

Algert Global reduced its Agios Pharmaceuticals (AGIO) stake by 7.6% in Q2 2026, selling an estimated $620K and leaving 248,007 shares worth $9.2M. The position accounts for 0.11% of the portfolio, ranked #299.

Algert Global first reported a position in AGIO in Q3 2022 and has held it in 12 quarters since. The position peaked at $11.3M in Q4 2025. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Algert Global held 248,007 shares of Agios Pharmaceuticals worth $9.2M as of Q2 2026.
  • Algert Global sold 20,428 Agios Pharmaceuticals shares in Q2 2026, an estimated $620K.
  • Agios Pharmaceuticals made up 0.11% of Algert Global's portfolio in Q2 2026, its #299 holding.
  • Algert Global first reported a position in Agios Pharmaceuticals in Q3 2022 and has held it in 12 quarters since.
  • Algert Global's Agios Pharmaceuticals position peaked at $11.3M in Q4 2025.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.